The MicroBeta2 System provides advanced radiometric and luminescent detection abilities for GPCRs, kinases, reporter gene assays, and traditional liquid scintillation counting. Providing coincidence counting, a unique patented configuration with two photomultiplier tubes that simultaneously detect signal, the MicroBeta2 System ensures high efficiency and extremely low background for a variety of radionuclides.
The MicroBeta2 System features time-resolved liquid scintillation counting (TR-LSC), delivering improved counting performance for opaque plates where traditional coincidence counting isn't possible.
Please enter valid quantity
Please log in to add favorites.
NULL OR EMPTY CART
21 CFR Part 11 Compatibility optionally available. Please consult your radiometric detection specialist.
Get more assays, from one powerful system
Choose the format that best suits your application
All the consumable and peripherals to help you get the results you've been looking for:
|21 CFR Part 11 Compatible||Yes|
Find out about our range of integrated solutions for drug discovery screening in this e-brochure.
Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.
Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.
Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.